These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9851439)

  • 41. Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Yamano Y; Jacobson S; Taylor GP; Martin F; Galvão-Castro B
    J Clin Virol; 2013 Nov; 58(3):584-6. PubMed ID: 24095029
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
    Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
    Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
    Lins L; de Carvalho VJ; de Almeida Rego FF; Azevedo R; Kashima S; Gallazi VN; Xavier MT; Galvão-Castro B; Alcantara LC
    J Med Virol; 2012 Sep; 84(9):1428-36. PubMed ID: 22825822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
    Montanheiro P; Vergara MP; Smid J; da Silva Duarte AJ; de Oliveira AC; Casseb J
    J Neuroimmunol; 2007 Aug; 188(1-2):138-42. PubMed ID: 17588676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HTLV-I production based on activation of integrin/ligand signaling in HTLV-I-infected T cell lines derived from HAM/TSP patients.
    Fukushima N; Nakamura T; Nishiura Y; Ida H; Aramaki T; Eguchi K
    Intervirology; 2008; 51(2):123-9. PubMed ID: 18552504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
    Nascimento MC; Primo J; Bittencourt A; Siqueira I; de Fátima Oliveira M; Meyer R; Schriefer A; Santos SB; Carvalho EM
    Clin Exp Immunol; 2009 Jun; 156(3):455-62. PubMed ID: 19438598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.
    Matsuzaki T; Nakagawa M; Nagai M; Nobuhara Y; Usuku K; Higuchi I; Takahashi K; Moritoyo T; Arimura K; Izumo S; Akiba S; Osame M
    J Neurovirol; 2000 Dec; 6(6):544-8. PubMed ID: 11175327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Ijichi S; Ijichi N; Osame M
    Nihon Rinsho; 1997 Apr; 55(4):926-33. PubMed ID: 9103896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy.
    Cavrois M; Leclercq I; Gout O; Gessain A; Wain-Hobson S; Wattel E
    Oncogene; 1998 Jul; 17(1):77-82. PubMed ID: 9671316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis and treatment of human T-cell lymphotropic virus Type I-associated myelopathy.
    Nagai M; Osame M
    Expert Rev Neurother; 2002 Nov; 2(6):891-9. PubMed ID: 19810922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological studies in tropical spastic paraparesis.
    Jacobson S; Gupta A; Mattson D; Mingioli E; McFarlin DE
    Ann Neurol; 1990 Feb; 27(2):149-56. PubMed ID: 2317010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Failure to detect HTLV-I proviral DNA in the liver of a patient with primary biliary cirrhosis and HTLV-I-associated myelopathy.
    Ijichi T; Miyata K; Nakajima K; Hashimoto K; Kashio N; Osame M
    Am J Gastroenterol; 1996 Apr; 91(4):827-8. PubMed ID: 8677978
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP.
    Enose-Akahata Y; Oh U; Ohayon J; Billioux BJ; Massoud R; Bryant BR; Vellucci A; Ngouth N; Cortese I; Waldmann TA; Jacobson S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1383-1394. PubMed ID: 31402625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
    Osame M; Nakagawa M; Umehara F; Ijichi S; Moritoyo T; Higuchi I; Usuku K; Arimura K; Izumo S
    J Neurovirol; 1997 May; 3 Suppl 1():S50-1. PubMed ID: 9179793
    [No Abstract]   [Full Text] [Related]  

  • 60. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.
    Rocha-Júnior MC; Haddad R; Cilião Alves DC; de Deus Wagatsuma VM; Mendes-Junior CT; Deghaide NH; Takayanagui OM; Covas DT; Donadi EA; Kashima S
    Tissue Antigens; 2012 Aug; 80(2):143-50. PubMed ID: 22587568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.